Primary graft dysfunction after liver transplantation.

Area of Science:

• Hepatology
• Transplantation Medicine
• Immunology

Background:

• Primary graft dysfunction (PGD) is a significant complication following liver transplantation, leading to poor patient prognosis.
• PGD is associated with extended intensive care unit (ICU) and hospital stays, increased mortality, and higher rates of graft loss.
• The absence of a universally accepted definition hinders early diagnosis and prediction of PGD.

Purpose of the Study:

• To analyze existing literature on primary graft dysfunction (PGD) in liver transplantation.
• To propose a standardized definition for PGD to facilitate early diagnosis and management.
• To review risk factors, characteristics, and potential treatments for PGD.

Main Methods:

• A comprehensive literature search of PubMed was conducted for English-language articles up to the end of 2012.
• The search focused on identifying characteristics, risk factors, and interventions related to PGD.
• Analysis of documented definitions and contributing factors to allograft dysfunction.

Main Results:

• No definitive pathological diagnostic standard for PGD currently exists, with varied definitions documented.
• Factors influencing graft function include donor status, procurement, transplant process, and recipient condition; ischemia-reperfusion injury is a primary cause.
• Several potential management strategies show promise for improving graft function.

Conclusions:

• A proposed definition for PGD includes: (1) bilirubin ≥ 10 mg/dL on postoperative day 7, (2) international normalized ratio (INR) ≥ 1.6 on postoperative day 7, or (3) alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >2000 IU/L within 7 postoperative days.
• Reducing identified risk factors may decrease the incidence of PGD.
• While most recipients recover, primary non-function necessitates re-transplantation.